PMID: 9189078Jun 1, 1997Paper

Aggressive multimodality treatment for locally advanced irresectable rectal cancer

The British Journal of Surgery
R FaroukL L Gunderson

Abstract

Local failure rates are high for locally irresectable primary or recurrent colorectal cancer, even when chemoradiation therapy is employed. This review evaluates evidence supporting aggressive preoperative chemoradiation followed by maximal surgical resection and intraoperative radiation therapy to achieve disease control and cure for patients with locally advanced irresectable primary or recurrent rectal cancer. A 5-year survival rate of 42 per cent with a central failure rate of 2 per cent may be achieved in patients with locally irresectable primary rectal cancer. In patients with locally recurrent disease, these values at 5 years are 18 and 28 per cent respectively. The 5-year incidence of distant metastasis remains high, affecting 64 per cent of patients with primary cancer and 75 per cent of those with recurrent cancer. A disease-free surgical resection margin remains paramount to achieve cure. Encouraging trends exist, however, for further evaluation of multimodality therapy as a means of reducing local recurrence of disease.

References

Jun 1, 1976·Cancer·K R StevensW S Fletcher
Sep 1, 1992·World Journal of Surgery·L Påhlman, B Glimelius
Jun 1, 1992·Annals of Surgery·H J WaneboS I Cohen
Oct 1, 1991·International Journal of Radiation Oncology, Biology, Physics·B D MinskyL B Harrison
Mar 14, 1991·The New England Journal of Medicine·J E KrookJ A Mailliard
Jul 1, 1990·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·E G ShawK C Podratz
Feb 8, 1990·The New England Journal of Medicine·C G MoertelJ H Glick
May 1, 1987·Annals of Surgery·H J WaneboW C Constable
Jun 15, 1989·Cancer·N W PearlmanR E Donohue
Dec 1, 1989·International Journal of Radiation Oncology, Biology, Physics·P E AlleeJ E Munzenrider
Jun 6, 1985·The New England Journal of Medicine·UNKNOWN Gastrointestinal Tumor Study Group
Feb 1, 1989·International Journal of Radiation Oncology, Biology, Physics·S E SchildR R Dozois
Jan 1, 1988·Annals of Surgery·L L GundersonD C McIlrath
Nov 13, 1986·The New England Journal of Medicine·H O DouglassUNKNOWN Gastrointestinal Tumor Study Group
Jan 1, 1985·The British Journal of Surgery·F T McDermottA B Price
Jul 1, 1985·International Journal of Radiation Oncology, Biology, Physics·L L GundersonJ E Tepper
Nov 1, 1972·Diseases of the Colon and Rectum·W A HindoF R Henrickson
Sep 1, 1972·Radiology·N Urdaneta-LafeeA H Knowlton
Apr 1, 1980·American Journal of Surgery·L L GundersonC E Welch
Nov 1, 1983·International Journal of Radiation Oncology, Biology, Physics·L L GundersonH D Suit
Oct 1, 1984·Diseases of the Colon and Rectum·O MellaG Odland
Jan 1, 1984·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M OvergaardA Sell
Jan 1, 1984·The British Journal of Surgery·R K PhillipsL P Fielding
Jan 1, 1983·Diseases of the Colon and Rectum·B J CummingsG M Thomas
Aug 1, 1982·International Journal of Radiation Oncology, Biology, Physics·B EmamiH H Miller
Oct 1, 1981·Annals of Surgery·H J Wanebo, R C Marcove
Oct 1, 1994·Annals of Surgery·H J WaneboD E Wrobleski
Jul 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R J Heald
Apr 30, 1995·International Journal of Radiation Oncology, Biology, Physics·G D WeinsteinD M Ota
Apr 30, 1995·International Journal of Radiation Oncology, Biology, Physics·C G WillettC C Compton
Jan 15, 1995·International Journal of Radiation Oncology, Biology, Physics·J D BrierleyP Goodman

❮ Previous
Next ❯

Citations

May 27, 1999·Diseases of the Colon and Rectum·L Ruo, J G Guillem
Jun 8, 2001·Diseases of the Colon and Rectum·G H MannaertsT Wiggers
Dec 17, 2008·International Journal of Colorectal Disease·Jun Jie WangSu Qing Tian
Nov 13, 2004·Diseases of the Colon and Rectum·Harvey G MooreJose G Guillem
Jun 17, 2006·Diseases of the Colon and Rectum·Genevieve B MeltonLarissa K Temple
Nov 7, 2002·International Journal of Radiation Oncology, Biology, Physics·Guido H H MannaertsTheo Wiggers
Feb 11, 1998·International Journal of Radiation Oncology, Biology, Physics·C S WongY Hao
Sep 16, 1999·International Journal of Radiation Oncology, Biology, Physics·G H MannaertsH J Rutten
May 10, 2000·International Journal of Radiation Oncology, Biology, Physics·G H MannaertsH J Rutten
Dec 10, 1999·Critical Reviews in Oncology/hematology·T Watanabe, T Muto
Oct 2, 2001·The British Journal of Surgery·A I SarelaD S O'Riordain
Jun 13, 2009·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·W ChambersC Cunningham
Jan 15, 2009·Annals of Surgical Oncology·A R SkandarajahA G Heriot
Nov 25, 2005·The British Journal of Radiology·D Tait
Mar 9, 2002·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·V ValentiniG Fiorentini
Feb 10, 2006·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·S G LarsenK-E Giercksky
Jun 28, 2005·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·G PalmerT Holm
Apr 6, 2001·Seminars in Surgical Oncology·C Rödel, R Sauer
Jun 5, 2003·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·S. R BrownA. J Shorthouse
Aug 11, 2007·Annals of the Royal College of Surgeons of England·R Bhardwaj, M C Parker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
K M TveitH J Schmoll
International Journal of Radiation Oncology, Biology, Physics
O AbuchaibeJ Alvarez-Cienfuegos
International Journal of Radiation Oncology, Biology, Physics
G H MannaertsH J Rutten
© 2021 Meta ULC. All rights reserved